{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:16:10Z","timestamp":1783523770962,"version":"3.55.0"},"reference-count":37,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn Circ J"],"published-print":{"date-parts":[[2000]]},"DOI":"10.1253\/jcj.64.547","type":"journal-article","created":{"date-parts":[[2002,9,9]],"date-time":"2002-09-09T02:05:36Z","timestamp":1031537136000},"page":"547-553","source":"Crossref","is-referenced-by-count":11,"title":["Plasma and Platelet Plasminogen Activator Inhibitor-1 in Patients With Acute Myocardial Infarction"],"prefix":"10.1253","volume":"64","author":[{"given":"Takeshi","family":"Soeki","sequence":"first","affiliation":[{"name":"Department of Cardiology and Clinical Research Institute, Zentsuji National Hospital, Zentsuji City, Kagawa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Clinical Research Institute, Zentsuji National Hospital, Zentsuji City, Kagawa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Clinical Research Institute, Zentsuji National Hospital, Zentsuji City, Kagawa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Ito","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Tokushima University School of Medicine, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Davies MJ, Thomas A: Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1137-1140","DOI":"10.1056\/NEJM198405033101801"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bini A, Fenoglio JJ, Sobel J, Owen J, Fejgl M, Kaplan KL: Immunochemical characterization of fibrinogen, fibrin I and fibrin II in human thrombi and atherosclerotic lesions. Blood 1987; 69: 1038-1045","DOI":"10.1182\/blood.V69.4.1038.1038"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Schwartz CJ, Valente AJ, Kelley JL, Sprague EA, Edwards EH: Thrombosis and the development of atherosclerosis: Rokitansky revisited. Semin Thromb Hemost 1988; 14: 189-195","DOI":"10.1055\/s-2007-1002775"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Thompson WD, Smith EB: Atherosclerosis and the coagulation system. J Pathol 1989; 159: 97-106","DOI":"10.1002\/path.1711590203"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sprengers ED, Kluft C: Plasminogen activator inhibitors. Blood 1987; 69: 381-387","DOI":"10.1182\/blood.V69.2.381.381"},{"key":"6","unstructured":"6. Loskutoff DJ, Sawdey M, Mimuro J: Type 1 plasminogen activator inhibitor. Prog Hemost Thromb 1989; 9: 87-115"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wiman B, Hamsten A: The fibrinolytic enzyme system and its role in the etiology of thrombo-embolic disease. Semin Thromb Haemost 1990; 26: 207-216","DOI":"10.1055\/s-2007-1002671"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Haverkate F, Thompson SG, Duckert F: Haemostasis factors in angina pectoris: Relation to gender, age and acute-phase reaction: Results of the ECAT Angina Pectoris Study Group. Thromb Haemost 1995; 73: 561-567","DOI":"10.1055\/s-0038-1653821"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Pedersen OD, Gram J, Jespersen J: Plasminogen activator inhibitor type 1 determines plasmin formation in patients with ischaemic heart disease. Thromb Haemost 1995; 73: 835-840","DOI":"10.1055\/s-0038-1653877"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Laug WE: Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells. Thromb Haemost 1985; 53: 165-169","DOI":"10.1055\/s-0038-1661265"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lundgren CH, Brown SL, Nordt TK, Sobel BE, Fujii S: Elaboration of type-1 plasminogen activator inhibitor from adipocytes: A potential pathogenetic link between obesity and cardiovascular disease. Circulation 1996; 93: 106-110","DOI":"10.1161\/01.CIR.93.1.106"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hamsten A, Wiman B, Faire UD, Blomback M: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557-1563","DOI":"10.1056\/NEJM198512193132501"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(87)90147-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gram J, Kluft C, Jesperson J: Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI). Thromb Haemost 1987; 58: 817-821","DOI":"10.1055\/s-0038-1645996"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lucore CL, Sobel BE: Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications. Circulation 1988; 77: 660-669","DOI":"10.1161\/01.CIR.77.3.660"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Barbash GI, Hod H, Roth A, Miller HI, Rath S, Zahav YH, et al: Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1989; 64: 1231-1235","DOI":"10.1016\/0002-9149(89)90559-6"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(92)90592-J"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sakamoto T, Yasue H, Ogawa H, Misumi I, Masuda T: Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction. Am J Cardiol 1992; 70: 271-276","DOI":"10.1016\/0002-9149(92)90603-V"},{"issue":"12","key":"19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1253\/jcj.58.869","volume":"58","author":"HONDA Y","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/0047-1828","issn-type":"print"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Simpson AJ, Booth NA, Moore NR, Bennett B: The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease. Br J Haematol 1990; 75: 543-548","DOI":"10.1111\/j.1365-2141.1990.tb07796.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Booth NA, Anderson JA, Bennett B: Platelet release protein which inhibits plasminogen activators. J Clin Pathol 1985; 38: 825-830","DOI":"10.1136\/jcp.38.7.825"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Booth NA, Simpson AJ, Croll A, Bennett B, MacGregor IR: Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol 1988; 70: 327-333","DOI":"10.1111\/j.1365-2141.1988.tb02490.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ludlam CA, Cash JD: Studies on the liberation of β-thromboglobulin from human platelets in vitro. Br J Haematol 1976; 33: 239-247","DOI":"10.1111\/j.1365-2141.1976.tb03535.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Jokl R, Laimins M, Klein RL, Lyons TJ, Lopes-Virella MF, Colwell JA: Platelet plasminogen activator inhibitor 1 in patients with type II diabetes. Diabetes Care 1994; 17: 818-823","DOI":"10.2337\/diacare.17.8.818"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Paramo JA, Colucci M, Collen D, van de Werf F: Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br Med J (Clin Res Ed) 1985; 291: 573-574","DOI":"10.1136\/bmj.291.6495.573"},{"key":"26","unstructured":"26. Oseroff A, Krishnamurti C, Hassett A, Taug D, Alving B: Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease. J Lab Clin Med 1989; 113: 88-93"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Juhan-Vague I, Alessi MC, Fossat C, Declerck PJ, Kruithof EKO: Plasma determination of plasminogen activator inhibitor 1 antigen must be performed in blood collected on antiplatelet\/anticoagulant mixture. Thromb Haemost 1987; 58: 1096","DOI":"10.1055\/s-0038-1646065"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Erickson LA, Ginsberg MH, Loskutoff DJ: Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest 1984; 74: 1465-1472","DOI":"10.1172\/JCI111559"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kruithof EKO, Tran-Thang C, Bachmann F: Studies on the release of a plasminogen activator inhibitor by human platelets. Thromb Haemost 1986; 55: 201-205","DOI":"10.1055\/s-0038-1661522"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(93)90241-F"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Vaughan DE, Declerck PJ, Van Houtte E, De Mol M, Collen D: Studies of recombinant plasminogen activator inhibitor-1 in rabbits: Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor 1 in vivo. Circ Res 1990; 67: 1281-1286","DOI":"10.1161\/01.RES.67.5.1281"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Konkle BA, Schick PK, He X, Liu RJ, Mazur EM: Plasminogen activator inhibitor-1 mRNA is expressed in platelets and megakaryocytes and the megakaryoblastic cell line CHRF-288. Arterioscler Thromb 1993; 13: 669-674","DOI":"10.1161\/01.ATV.13.5.669"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Alessi MC, Chomiki N, Berthier R, Schweitzer A, Fossat C, Juhan-Vague I: Detection of plasminogen activator inhibitor-1 (PAI-1) mRNA in human megakaryocytes by in situ hybridization. Thromb Haemost 1994; 72: 931-936","DOI":"10.1055\/s-0038-1648986"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Sprengers ED, Akkerman JWN, Jansen BG: Blood platelet plasminogen activator inhibitor: Two different pools of endothelial cell type plasminogen activator inhibitor in human blood. Thromb Haemost 1986; 55: 325-329","DOI":"10.1055\/s-0038-1661556"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Shimomura I, Funahashi T, Takahashi M, Maeda K, Nakamura T, Yamashita S, et al: Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity. Nat Med 1996; 2: 800-803","DOI":"10.1038\/nm0796-800"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Nakamura T, Tokunaga K, Shimomura I, Nishida M, Yoshida S, Kotani K, et al: Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994; 107: 239-246","DOI":"10.1016\/0021-9150(94)90025-6"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Hirashima O, Ogawa H, Oshima S, Sakamoto T, Honda Y, Sakata S, et al: Serial changes of plasminogen activator inhibitor activity in acute myocardial infarction: Difference between thrombolytic therapy and direct coronary angioplasty. Am Heart J 1995; 130: 933-939","DOI":"10.1016\/0002-8703(95)90191-4"}],"container-title":["Japanese Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jcj\/64\/8\/64_8_547\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T02:26:57Z","timestamp":1616725617000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jcj\/64\/8\/64_8_547\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000]]}},"URL":"https:\/\/doi.org\/10.1253\/jcj.64.547","relation":{},"ISSN":["0047-1828","1347-4839"],"issn-type":[{"value":"0047-1828","type":"print"},{"value":"1347-4839","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000]]}}}